4basebio to provide synthetic DNA to tier-one pharma firm
4basebio confirmed the provision of its synthetic DNA to an unnamed tier-one pharmaceutical company on Wednesday.
Stay updated with breaking news from 4basebio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
4basebio confirmed the provision of its synthetic DNA to an unnamed tier-one pharmaceutical company on Wednesday.
Biotechnology company 4basebio reported revenues from its DNA and Hermes products surpassing £0.2m in its first half on Thursday.
By Joe Hoppe 4basebio said Tuesday that it has received a grant from the Bill & Melinda Gates Foundation to advance its synthetic DNA and Hermes...
Synthetic DNA biotechnology specialist 4basebio announced a product supply agreement with Neomatrix on Thursday, which it described as an Italian biotech focussed on personalised cancer immunotherapies.
4basebio Plc - Director/PDMR Shareholding PR Newswire London, June 16 16 June 2022 4basebio plc (the "Company") Director's Dealings 4basebio PLC (AIM: